Anwaier A, Che X, Shi L, Tian X, Ye S, Xu W
J Natl Cancer Cent. 2024; 4(4):346-353.
PMID: 39735442
PMC: 11674429.
DOI: 10.1016/j.jncc.2024.06.001.
Yao Y, Liu Y, Yang T, Lu B, Yang X, Zhang H
Cancer Med. 2024; 13(12):e7336.
PMID: 39651783
PMC: 11192648.
DOI: 10.1002/cam4.7336.
Gu H, Lv J, Liu Y, Wang H
Front Oncol. 2024; 14:1444477.
PMID: 39512766
PMC: 11543353.
DOI: 10.3389/fonc.2024.1444477.
Song J, Liu L, Wang Z, Xie D, Azami N, Lu L
Heliyon. 2024; 10(7):e28329.
PMID: 38596115
PMC: 11002547.
DOI: 10.1016/j.heliyon.2024.e28329.
Wei M, Yang W, Xu W, Liu G, Xie Y, Dong J
BMC Urol. 2024; 24(1):60.
PMID: 38481245
PMC: 10935941.
DOI: 10.1186/s12894-024-01447-2.
Qualitative and quantitative characteristics of CEUS for renal cell carcinoma and angiomyolipoma: a narrative review.
Dipinto P, Canale V, Minelli R, Capuano M, Catalano O, Di Pierro G
J Ultrasound. 2024; 27(1):13-20.
PMID: 38238503
PMC: 10908740.
DOI: 10.1007/s40477-023-00852-x.
Construction of cuproptosis signature based on bioinformatics and experimental validation in clear cell renal cell carcinoma.
Tian X, Zhu S, Liu W, Wu X, Wei G, Zhang J
J Cancer Res Clin Oncol. 2023; 149(19):17451-17466.
PMID: 37889309
DOI: 10.1007/s00432-023-05259-z.
Factors predicting the active treatment of renal angiomyolipoma: 30 years of experience in two tertiary referral centers.
Dache A, Fatica R, Herts B, McLennan G, Remer E, Haber G
Front Surg. 2023; 10:1094806.
PMID: 37251582
PMC: 10210137.
DOI: 10.3389/fsurg.2023.1094806.
Perioperative, oncologic, and functional outcomes of robot-assisted partial nephrectomy for special types of renal tumors (hilar, endophytic, or cystic): an evidence-based analysis of comparative outcomes.
Chen X, Li Y, Wu T, Du Z, Tan C, Zhang Q
Front Oncol. 2023; 13:1178592.
PMID: 37152053
PMC: 10157041.
DOI: 10.3389/fonc.2023.1178592.
Optimal management of renal cell carcinoma in octogenarians: Retrospective analysis using updated Korean Renal Cell Carcinoma (KORCC) database.
Kim J, Jung G, Kwak C, Jeong C, Kang S, Hong S
PLoS One. 2023; 18(3):e0283483.
PMID: 36996119
PMC: 10062612.
DOI: 10.1371/journal.pone.0283483.
Long-term outcomes of radiofrequency ablation vs. partial nephrectomy for cT1 renal cancer: A meta-analysis and systematic review.
Li L, Zhu J, Shao H, Huang L, Wang X, Bao W
Front Surg. 2023; 9:1012897.
PMID: 36684152
PMC: 9852310.
DOI: 10.3389/fsurg.2022.1012897.
Recognizing pathology of renal tumor from macroscopic cross-section image by deep learning.
Lin Z, Yang W, Zhang W, Jiang C, Chu J, Yang J
Biomed Eng Online. 2023; 22(1):3.
PMID: 36670469
PMC: 9854121.
DOI: 10.1186/s12938-023-01064-4.
Theranostic Applications of Glycosaminoglycans in Metastatic Renal Cell Carcinoma.
Hua S, Viera M, Yip G, Bay B
Cancers (Basel). 2023; 15(1).
PMID: 36612261
PMC: 9818616.
DOI: 10.3390/cancers15010266.
Impact of Blood Loss on Renal Function and Interaction with Ischemia Duration after Nephron-Sparing Surgery.
Buse S, Mager R, Mazzone E, Mottrie A, Frees S, Haferkamp A
Curr Oncol. 2022; 29(12):9760-9766.
PMID: 36547181
PMC: 9777389.
DOI: 10.3390/curroncol29120767.
A Novel, Simple, and Low-Cost Approach for Machine Learning Screening of Kidney Cancer: An Eight-Indicator Blood Test Panel with Predictive Value for Early Diagnosis.
Li H, Wang F, Huang W
Curr Oncol. 2022; 29(12):9135-9149.
PMID: 36547129
PMC: 9776815.
DOI: 10.3390/curroncol29120715.
Pyroptosis-Related Gene Signature Predicts the Prognosis of ccRCC Using TCGA and Single-Cell RNA Seq Database.
Gan Y, Zhang Z, Wang X, Li A, Fan Y, Zhang Q
J Healthc Eng. 2022; 2022:8224618.
PMID: 36349258
PMC: 9637477.
DOI: 10.1155/2022/8224618.
Positive surgical margin's impact on short-term oncological prognosis after robot-assisted partial nephrectomy (MARGINS study: UroCCR no 96).
Morrone A, Bentellis I, Bernhard J, Bensalah K, Champy C, Bruyere F
Sci Rep. 2022; 12(1):18342.
PMID: 36316438
PMC: 9622828.
DOI: 10.1038/s41598-022-23146-4.
A Comparison of Functional and Oncologic Outcomes between Partial Nephrectomy and Radiofrequency Ablation in Patients with Chronic Kidney Disease after Propensity Score Matching.
Ryoo H, Kang M, Sung H, Jeon H, Jeong B, Jeon S
Diagnostics (Basel). 2022; 12(10).
PMID: 36291981
PMC: 9600482.
DOI: 10.3390/diagnostics12102292.
The effectiveness of off-clamp and non-renorrhaphy technique regarding postoperative renal function in patients with partial nephrectomy.
Iinuma K, Nakane K, Koie T
Transl Androl Urol. 2022; 11(9):1222-1223.
PMID: 36217402
PMC: 9547163.
DOI: 10.21037/tau-22-571.
A Randomized Multi-institutional Phase II Trial of Everolimus as Adjuvant Therapy in Patients with Locally Advanced Squamous Cell Cancer of the Head and Neck.
Nathan C, Hayes D, Karrison T, Harismendy O, Flores J, Moore-Medlin T
Clin Cancer Res. 2022; 28(23):5040-5048.
PMID: 36194164
PMC: 9722644.
DOI: 10.1158/1078-0432.CCR-21-4290.